Atrion Corp
NASDAQ:ATRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Atrion Corp
Cash from Investing Activities
Atrion Corp
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Atrion Corp
NASDAQ:ATRI
|
Cash from Investing Activities
-$8.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
18%
|
CAGR 10-Years
1%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Investing Activities
-$74.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cash from Investing Activities
$122.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Investing Activities
-$112.4m
|
CAGR 3-Years
19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Investing Activities
-$627.2m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-164%
|
CAGR 10-Years
-47%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cash from Investing Activities
-$247.4m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-15%
|
|
Atrion Corp
Glance View
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.
See Also
What is Atrion Corp's Cash from Investing Activities?
Cash from Investing Activities
-8.2m
USD
Based on the financial report for Jun 30, 2024, Atrion Corp's Cash from Investing Activities amounts to -8.2m USD.
What is Atrion Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
1%
Over the last year, the Cash from Investing Activities growth was -1 252%. The average annual Cash from Investing Activities growth rates for Atrion Corp have been 22% over the past three years , 18% over the past five years , and 1% over the past ten years .
